Clinical Trials
2 trialsNCT07551596 2026-05-15
Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial
National Cancer Institute (NCI)
Phase 2 Not yet recruiting
NCT07550088 2026-04-24
BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases
Scripps Health
Phase 2 Not yet recruiting